SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Emisphere -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (232)10/29/2005 1:46:26 PM
From: hmpa  Read Replies (2) | Respond to of 272
 
Similar is not equivalent

If FDA thinks it is good enough, EMIS will be allowed to run relatively short Phase 3 (<1000 patients),and that's what they are gearing for with the last financing. If they think otherwise company could be expected to abandon the project since they don't have nor will they get money to run a 4000 patients ++ trial.